Intuitive Surgical Reports Strong Q2 2026 Earnings

Intuitive Surgical (ISRG) reported Q2 2026 revenue of $2.89 billion, up 19% year-over-year from $2.44 billion, driven by growth in procedure volume and installed base expansion. GAAP diluted EPS was $2.29 (vs. $1.81 in Q2 2025), with non-GAAP diluted EPS at $2.80 (vs. $2.19), while worldwide procedures grew approximately 16% with da Vinci placements reaching 468 units including 246 da Vinci 5 systems.

Why it matters: The da Vinci installed base grew 12% to 11,710 systems and Ion to 1,096 systems as of June 30, 2026; ISRG shares rose 3.43% to $402.33 following the earnings release.